Symposium I: "Medicinal Chemistry and SAR in Hit-to-Lead Development"
Symposium II: "Preclinical Drug Discovery for Novel Oncology Therapeutics"
Symposium III: "Target Validation and Enabling Preclinical Technologies"
Symposium IV: "Nucleic Acids-Based Therapeutics, Gene Editing and Antiviral Therapeutics"
Symposium V: "Cannabinoids and Terpenes Targeting of the Endocannabinoid System"
Symposium VI: "Optimizing Cannabis Cultivars and Products for Medicinal Efficacy"